(Q37274449)

19 August 2017

1 reference

title

Exploitation of the folate receptor in the management of cancer and inflammatory disease (English)

1 reference

19 August 2017

0 references

1 reference

Christopher P Leamon

1

1 reference

PubMed ID

18804696

19 August 2017

Ann L Jackman

series ordinal

2

1 reference

19 August 2017

1 January 2008

1 reference

19 August 2017

Vitamins and Hormones

1 reference

19 August 2017

79

1 reference

19 August 2017

203-233

1 reference

Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Design and synthesis of Cyclopenta[g]quinazoline-based antifolates as inhibitors of thymidylate synthase and potential antitumor agents(,).

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

The design and synthesis of water-soluble analogues of CB30865, a quinazolin-4-one-based antitumor agent

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Internalization and intracellular transport of folate-binding protein in rat kidney proximal tubule

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Cancer immunotherapy: a treatment for the masses

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Dosimetric analysis of chimeric monoclonal antibody cMOv18 IgG in ovarian carcinoma patients after intraperitoneal and intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Lack of impact of the loss of constitutive folate receptor alpha expression, achieved by RNA Interference, on the activity of the new generation antifolate pemetrexed in HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Arthritis imaging using a near-infrared fluorescence folate-targeted probe

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

The history of the development and clinical use of CB 3717 and ICI D1694

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

The dynamics of folic acid metabolism in an adult given a small tracer dose of 14C-folic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

In vivo tumor targeting of a recombinant single-chain antigen-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Role of folate receptor genes in reproduction and related cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Flow cytometric method for determining folate receptor expression on ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate receptor overexpression is associated with poor outcome in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Targeting the alpha-folate receptor with cyclopenta[g]quinazoline-based inhibitors of thymidylate synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Mediated uptake of folate by a high-affinity binding protein in sublines of L1210 cells adapted to nanomolar concentrations of folate

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

A high-affinity folate binding protein in proximal tubule cells of human kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

99mTc-ethylenedicysteine-folate: a new tumor imaging agent. Synthesis, labeling and evaluation in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Antifolates targeted specifically to the folate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Receptor-mediated folate accumulation is regulated by the cellular folate content

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate-maytansinoids: target-selective drugs of low molecular weight

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate-mediated targeting: from diagnostics to drug and gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate-targeted chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate-mediated drug delivery: effect of alternative conjugation chemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Synthesis and biological evaluation of EC72: a new folate-targeted chemotherapeutic

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Synthesis and biological evaluation of EC140: a novel folate-targeted vinca alkaloid conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Preclinical antitumor activity of a novel folate-targeted dual drug conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Comparative preclinical activity of the folate-targeted Vinca alkaloid conjugates EC140 and EC145.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Altered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate-targeted immunotherapy in hapten-immunized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Complete mapping of divergent amino acids responsible for differential ligand binding of folate receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Membrane transport of folates

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Human reduced folate carrier: translation of basic biology to cancer etiology and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

A kit formulation for preparation of [(111)In]In-DTPA-folate, a folate-receptor-targeted radiopharmaceutical

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Synthesis of [(99m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Immunoscintigraphy with three step monoclonal pretargeting technique in diagnosis of uveal melanoma: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Synthesis and in vitro/in vivo evaluation of novel 99mTc(CO)3-folates.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

In vitro and in vivo efficacy of a recombinant immunotoxin against folate receptor beta on the activation and proliferation of rheumatoid arthritis synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Effectiveness of anti-folate receptor beta antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Selective expression of the high-affinity isoform of the folate receptor (FR-alpha) in the human placental syncytiotrophoblast and choriocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Targeting therapeutic and imaging agents to folate receptor positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate receptor specific anti-tumor activity of folate-mitomycin conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Cell surface antigens of human trophoblast and choriocarcinoma defined by monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

The folate receptor: what does it promise in tissue-targeted therapeutics?

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

A simple qualitative determination of human antibodies to murine immunoglobulins (HAMA) in serum samples

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

The role of alpha-folate receptor-mediated transport in the antitumor activity of antifolate drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Overexpression of folate binding protein in ovarian cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

The folate receptor in central nervous system malignancies of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900407-X

7 January 2021

10.1016/S0083-6729(08)00407-X

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18804696